Marques Tiago

Marques Tiago is listed in filings as Chief Executive Officer at Pasithea Therapeutics Corp.. This profile follows SEC Form 4 activity through May 5, 2026, including purchase activity and sale activity. Recent filings connect the profile to Pasithea Therapeutics Corp. (KTTAW) and Pasithea Therapeutics Corp. (KTTA). The current snapshot covers public activity from May 14, 2025 to May 5, 2026. Reported amounts are shown as $1.5M to $352.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.